Dr. Seigne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Lebanon, NH 03756Phone+1 603-650-5091
Education & Training
- University of Texas Health Science Center at HoustonResidency, Urology, 1993 - 1996
- Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 1989 - 1993
- Massachusetts General HospitalResidency, Surgery, 1987 - 1989
- University of Dublin Trinity CollegeClass of 1986
Certifications & Licensure
- NH State Medical License 2004 - 2026
- VT State Medical License 2022 - 2026
- FL State Medical License 1996 - 2006
- MA State Medical License 1991 - 2006
- TX State Medical License 1995 - 2005
- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACS) American College of Surgeons
Clinical Trials
- R115777 in Treating Patients With Advanced Bladder Cancer Start of enrollment: 2000 Mar 01
- CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2013 Sep 10
Publications & Presentations
PubMed
- 932 citationsDiagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineSam S. Chang, Stephen A. Boorjian, Roger Chou, Peter E. Clark, Siamak Daneshmand
The Journal of Urology. 2016-10-01 - 100 citationsThe specific role of isoflavones in reducing prostate cancer risk.Nagi B. Kumar, Alan B. Cantor, Kathy Allen, Diane Riccardi, Karen Besterman-Dahan
The Prostate. 2004-05-01 - 38 citationsIL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).Russell K. Pachynski, Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard Joseph Appleman
Journal for Immunotherapy of Cancer. 2021-08-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: